# Association of tumor mutational burden (TMB) and clinical outcomes with pembrolizumab (pembro) versus chemotherapy (chemo) in patients with metastatic triple-negative breast cancer (mTNBC) from KEYNOTE-119.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-of-tumor-mutational-burden-tmb-and-clinical-outcomes-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eric P. Winer,Oleg Lipatov,Seock‐Ah Im,Anthony Gonçalvès,Eva Muñoz‐Couselo,Keun Seok Lee,Peter Schmid,Laura Testa,Isabell Witzel,Shoichiro Ohtani,Jared Lunceford,Vassiliki Karantza,Jaime Mejia,Răzvan Cristescu,Deepti Aurora-Garg,Petar Jelinic,Lingkang Huang,Javier Cortés |
| Citations | 62 |
| DOI | 10.1200/jco.2020.38.15_suppl.1013 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3032152696 |
| Type | conference-abstract |
| Year | 2020 |

## Paper authors

- [Jaime Mejia](https://scholariq.org/researchers/jaime-mejia/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.